T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Ventas
VTR
$46.3B
| $30.8M | 0.01% |
420,168
+18,644
| +5% | +$1.39M |
|
1002
Viatris
VTRS
$18.4B
| $30.5M | 0.01% |
592,480
+6,590
| +1% | +$324K |
|
|
RAI
1003
DELISTED
Reynolds American Inc
RAI
| $30.5M | 0.01% |
1,011,556
+41,200
| +4% | +$1.18M |
|
1004
Parker-Hannifin
PH
$134B
| $30.5M | 0.01% |
242,475
+10,300
| +4% | +$1.28M |
|
1005
Waste Management
WM
$89.6B
| $30.4M | 0.01% |
679,601
-6,510
| -0.9% | -$283K |
|
1006
Coca-Cola Consolidated
COKE
$12.7B
| $30.4M | 0.01% |
4,125,900
+25,000
| +0.6% | +$195K |
|
|
STAY
1007
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $30.4M | 0.01% |
1,310,500
+33,600
| +3% | +$756K |
|
|
CBK
1008
DELISTED
Christopher & Banks Corporation
CBK
| $30.2M | 0.01% |
3,445,597
+1,400
| +0% | +$9.68K |
|
1009
Veeco
VECO
$3.28B
| $29.7M | 0.01% |
797,640
+4,150
| +0.5% | +$148K |
|
1010
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $29.6M | 0.01% |
750,697
-46,247
| -6% | -$1.66M |
|
1011
Edison International
EIX
$27.2B
| $29.6M | 0.01% |
509,263
-2,885,690
| -85% | -$162M |
|
|
OREX
1012
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $29.6M | 0.01% |
478,640
+215,189
| +82% | +$12.5M |
|
|
TXTR
1013
DELISTED
TEXTURA CORPORATION COM
TXTR
| $29.5M | 0.01% |
1,249,400
+508,600
| +69% | +$10.4M |
|
1014
Mueller Water Products
MWA
$3.98B
| $29.5M | 0.01% |
3,411,377
+186,750
| +6% | +$1.65M |
|
1015
Zimmer Biomet
ZBH
$19B
| $29.4M | 0.01% |
291,929
+14,832
| +5% | +$1.45M |
|
|
IVAC
1016
DELISTED
Intevac Inc
IVAC
| $29.3M | 0.01% |
3,652,830
-1,700
| -0% | -$13.7K |
|
|
HTS
1017
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $29.2M | 0.01% |
1,471,670
+41,900
| +3% | +$830K |
|
1018
Rockwell Automation
ROK
$49.5B
| $29.1M | 0.01% |
232,520
+9,600
| +4% | +$1.18M |
|
1019
Polaris
PII
$3.91B
| $29M | 0.01% |
222,375
+61,884
| +39% | +$8.2M |
|
|
CTT
1020
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $28.6M | 0.01% |
2,094,520
+5,400
| +0.3% | +$72.6K |
|
|
WPP
1021
DELISTED
WAUSAU PAPER CORP.
WPP
| $28.6M | 0.01% |
2,640,810
-10,700
| -0.4% | -$119K |
|
1022
Clean Harbors
CLH
$16.9B
| $28.4M | 0.01% |
442,280
+314,300
| +246% | +$18.7M |
|
1023
Affiliated Managers Group
AMG
$9.7B
| $28.2M | 0.01% |
137,289
+69,502
| +103% | +$13.4M |
|
|
SWN
1024
DELISTED
Southwestern Energy Company
SWN
| $28.1M | 0.01% |
618,565
-2,600
| -0.4% | -$120K |
|
|
SHLO
1025
DELISTED
Shiloh Industries Inc
SHLO
| $27.8M | 0.01% |
1,506,190
+7,200
| +0.5% | +$135K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.